Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up.
Ho C, Gopal AK, Till BG, Shadman M, Lynch RC, Cowan AJ, Wu QV, Voutsinas J, Rasmussen HA, Blue K, Ujjani CS, Cassaday RD, Fromm JR, Fang M, Smith SD.
Ho C, et al. Among authors: fromm jr.
Clin Lymphoma Myeloma Leuk. 2024 Feb;24(2):e33-e39.e1. doi: 10.1016/j.clml.2023.10.002. Epub 2023 Oct 18.
Clin Lymphoma Myeloma Leuk. 2024.
PMID: 37926672